lilly ledbetter. the bill. strengthen >> good morning. it is a great morning. so excited to be here. i'm rosa delaura and represent the 3rd district of connecticut. thank you to all of you for joining us this thorning. i can't tell you how proud i am to stand with our colleagues and champions and our leader, nancy pelosi. thank you to the folks, the champions on here. the organizations and the individuals who never flagged for a moment in advocating for equal pay for equal work. today, we are introducing the fairness act the bill that has the support of every democratic member of our caucus. and one republican. [applause] ms. delauro: our senate colleague, senator murray hosted a companion legislation and there are 47 senate democrats on the legislation there as well. and lord knows, we have been in this fight side-by-side for many years. i want to -- i will move quickly. we have a wonderful group of people here to speak and also other colleagues who are here to support us in this effort. e have a maj

for lilly it will work for merck that's way wall street thinks.nkly, it might even be better for merck because their animal business is more attractive than elanco the business was basically stagnant, hardly any sales growth in 2015 merck's sale is larger that's even better than the mid single digit growth that the company's core pharmaceutical business i want a piece of this now you think this high quality animal health asset would help pull merck's valuation higher, and i actually think merck believes that. i don't believe that's the case at all they know drugs. i know stocks. the problem is buried within the larger company, no one's going to pay attention to it most money managers hate complexity they want nice clean simple stories because they'd rather watch netflix when they get home or have a cocktail i don't know what they do, but it's not the kind of work. they don't look at merck they ignore the veterinary biz they don't give it any credit. that's why a breakup makes so much sense i bet its stock gets a dramatically higher price-to-earnin

initially eli lilly took a hit loxo's technology is visionary and now belongs to lilly and the stockent higher because of it. for a long time when we thought of pharma, we thought of drugs for the same old remedies. sales forces that pushed product. but that is no longer the case that is what is so exciting about being out here take novartis, a doctor, got a master degree of public policy from harvard and happens to be an actual scientist. this guy is reinventing it maybe solutions, i do. many of which could be turned out to be blockbusters that produce billions of shares you will hear from him later tonight. pay close attention to what he is doing with gene therapy, and heart therapy. how about emma wongsly who runs glaxo. yielding 5%. really exciting. that is what many investors want from big pharma, but not me. i want breakthroughs, life saving products. until they got there, the product didn't seem it could innovation walmsly could combined products. number one or number two brands in a host of categories. advil, chapstick, tums excedrin i like it. some good cash flow, dominant p

dave ricks, chairman and ceo of eli lilly. >> jim reporting from the jpmorgan healthcare conference and a lot more to come from him, and as we head to break a quick check on the major averages. nasdaq and s&p both higher "squawk on the street" back right after this duncan just protected his family with a $500,000 life insurance policy. how much do you think it cost him? $100 a month? $75? $50? actually, duncan got his $500,000 for under $28 a month. less than a dollar a day. his secret? selectquote. in just minutes, a selectquote agent will comparison shop nearly a dozen highly-rated life insurance companies, and give you a choice of your five best rates. duncan's wife cassie got a $750,000 policy for under $22 a month. give your family the security it needs at a price you can afford. >>> time for our etf spotlight this morning taking a look at utilities. the utility select sector etf and xlu lagging amid pg&e's liability concerns surrounding the devastating california wildfires which david reported on earlier this morning. so

eli lilly is the latest drug company to make a big bet on lo on. as the science evolves and ground-breaking new medicines are discovered. >>> pricing power. it's going to cost you more to go to disneyland, but wills consumeray up? those stories and much more tonight on "nightly business report." it i monday, january 7th. >>> good evening, everne, and welcome. the big rally friday extended into today. investors started the week in a buying mood, snapping up shares of technology stocks, as u.s. and chinese officials talked trade and the price of oil rose. the dow jones industrials rose 98 points to 23,531. the nasdaq added 84, the s&p 500 was up 17. asusual, there w volatility. but there was also a sense of relief, which stand contrast to what investors were feeling not too long ago.sa bob explains. >> it's remarkable how much market sentiment has changed just over the past few days. investors h had a long list of concerns but they're finally starting to see some progress s made oneral fronts. there were worries about the fed raising rates too quickl

it is a big premium, certainly a big deal price, at least by lilly standards.other companies are left now? one analyst at the beginning of the year said there wouldn't be any big deals. there are already two. are there more to come? reporter: i think absolutely. we are in the middle of the jpmorgan health care conference for this industry, so that is why we are seeing a lot of splashy announcements this morning. celgenek we got a huge -bristol-myers news. if a company like celgene is billion,en out for $74 some of these other companies we've always thought of as a choirs -- as a choir -- as acquirers, all eyes are going to be on the large biotech stocks at jpmorgan. gilead, biogen, and all of your smaller biotechs as well. guy: a lot of this seems to focus on oncology. are there other areas of the market being left behind as a result of that, potentially creating opportunities? reporter: i think that is a really interesting point, something that the eli lilly ceo brought up on the call. they are going to be looking for opportunities in neuroscience and diabetes

that was daybreak's, the eli lilly ceo in sandbox -- that was dave ricks, the eli lilly ceo.more coming from that conference, i assure you.back to the breaking we had that, deutsche bank come at the company is said to be cutting its pool for 2018 by roughly 10%. frankfurtned now from . how are they going to do this without losing staff? >> that is the question they need to answer. cost are extreme pressures, but they are also under pressure not to lose that so they are trying to allocate bonuses selectively and try to reward those who bring in the most money and not reward those who do not bring in money, thereby saving costs are not the top earners, and that will be how they will try to spread the circle. vonnie: we are hearing this about deutsche bank, presumably other banks will come out with a statement on bonuses. context?ut it into what are we hearing about bonuses and other european banks and in general global banks? well, i think banks generally have seen a share prices that have seen bad year in 2018 and there is a lot of competition. we had a report before the winte

the eli lilly ceo saying they are looking to do more deals this year.ocused on rebuilding the pipeline so he said they could be looking to do more cancer deals but also neuroscience and immunology. there could be a lot more to come from eli lilly as well as more probably. vonnie: thank you very much. it is time for the latest bloomberg business flash. couldars of wildfires lead pg&e to file for bankruptcy protection. shares are plunging today. bloomberg has learned the company is considering bankruptcy because of billions of dollars in liability may face from wildfires their equipment may have started. the legislature to come up with a rescue package. they are preparing for liquidation that could cost thousands of jobs. plan to buy's stores out of bankruptcy fell short. sears will focus on getting ready for liquidation sales that could begin as early as the middle of january. that is the latest bloomberg business flash. checking u.s. markets, it is about three hours into the trading session. we have the s&p 500 up 21%. the nasdaq is up 1.5% on a slightl

bid well lillies stock fell one point five percent. and the latest effort by the united states to curb chinese economic diplomacy targets a prominent u.s. client state israel u.s. national security adviser. john bolton has expressed concerns to israeli prime minister benjamin netanyahu over the wall of chinese companies in israeli infrastructure mr bolton cited in israeli agreement from twenty fifteen that calls for the shanghai international support group or s i.p.g. whose majority shareholder is the chinese government to manage the civilian port of haifa for twenty five years beginning in twenty twenty one haifa of support also host vessels from the u.s. navy's six fleet leading to mr bolton's concern over operational security at the port israeli officials are said to be working to address u.s. concerns. and other news of apparent international economic intrigue earlier today taiwan's criminal investigative bureau or cia be announced it has arrested six current or former employees of the local subsidy or a german judge chemical giant

this is the biggest deal that eli lilly has ever done. it's with a cancer company, loxo.f people'sa lot radars as a takeover target. it's unusual that eli lilly would be the buyer but it shows they are committed to cancer and rebuilding their pipeline. loxo does.lain what has it been doing so far in what's in their pipeline? an interesting company, working on one of the most cutting areas of oncology. it's known as precision medicines a rather than working on cancer drugs that target lung cancer or breast cancer or whatever the case may be, they work on drugs that target mutations.netic they won their first fda approval last november. that drug is tumor agnostic which means it's targeting a specific genetic marker of cancer tumors rather than where those tumors are in the body. prices haveeems been gyrating wildly for these pharma companies. how are analysts pricing them? how are management teams and investors pricing them? >> that's what has been interesting. 2018, after tax reform, analysts and investors, we thought we &auld go get investors with m a few big deal to not

those included groups of neighbors from another directly abutting property at 75 lilly street and also a group of neighbors from across the street directly across the street at 55 page street. in addition, we also made our reaches to mr. collins, who owns but doesn't live at 76 page. we never heard any further comments from residents at 76 page during the period of time it was being reviewed and designed. there was no request for a discretionary review at planning. after those meetings we had with the two groups of direct neighbors from lilly and page street we made changes to the design. we put in the noise screens that were described for privacy and light shielding. we also made numerous changes to the facades that were facing page street and lilly street based on neighbor and planning department input. during the course of all of this, we did have numerous conversations with mr. collins, who i believe was acting in the interest of his tenants. we did make several changes along the property line as discussed. we made several offers to mr. collins. when i informed him, proactively in

that shows you how much eli lilly wanted company.cewaterhousecoopers one of the consulting firms says there is more like this to come. alluded to the fact with cancer treatments, when patients are paying for drugs, the pharmaceutical companies are reaping anywhere between 60, to 80% premium and these pharmaceutical companies don't actually have to pay a sales force. a high cost sales force the same extent they do with other kinds of treatments, neil. neil: analogy of built-in babe ruth. you just bought babe ruth. jonathan, when you look at the sector, do you like it or all of sudden change valuation, far from encouraging deals it might inhibit them? >> no, neil. deirdre is right on the money. this is quietly one of the strongest performing sectors in 2018. everything fell apart in the fourth quarter. up until this point it was big cat pharmaceutical stocks. it survived as a big cap pharmaceutical you have to be involved in m&a. all the top 10 pharmaceutical companies globally are products of m&a. bristol-myers acquire celgene. takida

lilly is now discussing what comes next with regulators. shares dropped 2% today to $116.59. >>> and schlumberger reported quarterly revenue that toppema ess. given the volatility in crude, the ceo says his company's spending outlook remains uncertain. it is considered a bellwether for the oil field services sector,nd that stock popped pie 8% to $44.73. >>> time for our weekly market monitor who h aix of large and hadcap companies tt he sees growing double digits over the next year. he is david rainey, portfolio manager. lcome back, nice to see you again. >> good to be here. >> and you pick these from differ.t industri you say that basically they're all going to groonderably over the next couple of years. let's start with your first pick, whichri is an tower. a big cell phone operator with internional aspirations. >> sure. american tower is this country's largest cell tower owner/operator. they both acquire and build sites. the u.s. market is running and gunning rig now. all four wireless carriers are aggressively rolling outic se and techn

eli lilly shares are up 3% on the news.gan health care conference. shutdown showdown, we are in week three now of the partial government shutdown over funding for a border wall. president trump says he now is planning for a steel wall instead of a concrete wall. calling it stronger and less objecobtrusive. we'll have details on the extraordinary steps the trump administration is taking to keep national parks open during this shutdown. well, a word on privacy, apple is taking a swipe at google and facebook with a full billboard across from this year's consumer electronics show. we'll tell you about it. wait until you see this. big names set for ipos this year, we're taking a look at the most hotly anticipated offerings for the new year. new year. we've got familiar names like uber, lyft, airbnb, going public this year. we've got a preview. check out this video from the world's largest ice festival in china. more on the incredible visuals coming up this morning. all those stories coming up this monday morning. joining me to b

potential blockbuster drugs already unlocks those pipeline seem to have inspired a generous bid with lilly offering two hundred thirty five dollars per share for a lock so stock a premium of nearly seventy percent over locks those price at the close of trading on friday listen to this lock so those shares surged today by more than sixty five percent on the news of the merger just three dollars shy of the lilly bid while lili's stock fell one point five percent. and the latest effort by the united states to curb chinese economic diplomacy targets a prominent u.s. client state israel u.s. national security advisor john bolton has expressed concerns to israeli prime minister benjamin netanyahu over the wall of chinese companies in israeli infrastructure mr bolton cited in israeli agreement from twenty fifteen that calls for the shanghai international support group or s i.p.g. whose majority shareholder is the chinese government to manage the civilian port of haifa for twenty five years beginning in twenty twenty one haifa support also host vessels from the u.s. navy's six fleet leading to mr

. >> reporter: little lilly johnson faces another week in quarantine. >> freaking out at every little every little cough. >> yeah, everything. >> reporter: the 7-month-old might have been exposed to a growing measles outbreak when she visited a nearby clinic in vancouver, washington. >> i've just gotten to the point where i'm angry. >> reporter: he's angry because doctors believe lilly, still to young for a vaccination, was put at risk by people who chose not to vaccinate their children. >> some of those folks are out there in force. it's really unfortunate they're doing damage. they're doing serious damage. because death can result from this. >> reporter: pediatrician paul thomas treats hundreds of vaccine-hesitant families. >> they have concerns about the safety of vaccines. so, they're hesitant to do a vaccine. >> reporter: and tonight, in hawaii, doctors say they're on the lookout for a measles outbreak after two people exposed to measles in washington state visited hawaii. public health experts are already watching 14 so-called hot spots around the country where they're seeing a

eastern time, an interview with eli lilly c.e.o. david rick.from that same kfrpblts >> president trump says he will address the nation tomorrow night about what he says is a risis at the u.s.-mexico border. mr. trump maintenance that more han $5 million for a -- $5 billion for a wall is needed to secure the border. the internal revenue service will issue refunds to taxpayers even if the u.s. government shutdown extends into the filing season. the acting director of the white house office of management and budget said "tax refpblets will go out." in previous shutdown contingency plans, the i.r.s. would accept tex refunds but refunds would be delayed until the government was funded. hillary clinton joifpbled andrew cuomo today for strengthening abortion rights in new york state law. it didn't give women the same rights gaurnl teed under roe v. wade. >> the struggle for women's quality is not simply something to be read about in the pages of your history books. it continues to be the fight of our life tivement women's abilities to get basic health

in pharma, eli lilly will acquire loxo. >> this is the largest transaction eli lilly has ever done accordingerg data. it is interesting. there are paying about $8 billion, and investors seem to like it. it is certainly a premium price, but they do have a premium product. it is less risky. >> it is an incredible little company that took advantage of breaking science that allows doctors to identify the exact reason tumors are growing through genetic testing and then they make a drugs but block that action. it is entering the world of what we call precision medicine. it adds to our oncology business. the kind of transaction we said we would be interested in. strong innovation, compelling data from patients in terms of survival rates and complete response rates. we are excited to add it. >> german industrial production took a big step down in the last year, raising the prospect of a technical recession and european economic confidence has fallen to its lowest level in nearly two years. what is going on? >> well, i will tell you i think markets are shrugging this off. this is data from november a

>> me acompaÑa la seÑora lilly barrera y hÉctor jimeese quiÉ q se trata?os mostrar la fotografÍa. >> ¿cuÁndo fue la Última noticia? >>> que saliÓ con sus primos a esta fuga >>> ha formado parte de esta comitivo ciudadana que ha podido ingresar cuÁles son las averiguaciones o avances de las autoridades que les han avisado a ustedes? >>> en la maÑana despuÉs de formarse nos trataron muy bien y nos organizaron para que pudiÉramos entrar rÁpidamente mÁs bien, de par en par, a localizar o ver si se encontraban los cadÁveres para constatar >>> constatar que todo se estaba haciendo bien y el programa es que van a seguir en la noche van a desenterrar mÁs de este lado >> me comentaba usted que esta zanja que vemos a nuestras espaldas es porque entraron pipas y la tierra se acumulÓ y podrÍan haber mÁs cuerpos? >>> sÍ, la zanja se tapÓ al lado de dÓnde estaba la fuga para qu pudiera estar las unidades y se cree que debajo de esa tierra que se tapÓ la zanja hay mÁs cadÁveres. >> sabemos que desde diciembre se han registrado 10 fugas cuÁl es la diferencia de estÁs fuga

. >>> welcome back to "fast money," eli lilly purchased loxo oncology, the deal sent the etf that tracks the biotech space up more than 3% nearly 10% since the start of the year jim cramer sat down with a number of ceos in the space at the annual j.p. morgan health conference here's what the ceo had to say about growth at its company. >> we have four areas of big growth right now we have cancer portfolio growing, cardiovascular portfolio growing, bone health and migraine and then nugs we're launching biosimilar medicine which is we expect to be an important source as well so we expect to be a company that continues to grow handsomely on the top line and earnings per share over the long term. >> for the full interview with jim cramer and the ceo of amgen, stick around for "mad money" at the top of the hour. so should investors keep betting on biotech and the health care space? two major acquisitions in two weeks. >> i think so. this is not monday morning quarterback stuff. this is something we've been saying for some time, probably since earlier in the spring. i do think valuations are st

the major investment in juul the downgrade hurting the stock and loxo oncology after eli lilly agreed to buy the company. we'll hear about the ceo and bristol-myers ceo on the acquisition of cell gene or the one awarded by the people? uh... correct! you don't have to choose, 'cause, uh... oh! (vo) switch to the network awarded by rootmetrics and j.d. power. buy the latest galaxy phones, get galaxy s9 free. i am a techie dad.n. i believe the best technology should feel effortless. like magic. at comcast, it's my job to develop, apps and tools that simplify your experience. my name is mike, i'm in product development at comcast. we're working to make things simple, easy and awesome. >>> tumultuous times ahead for altria invested in juul vivian, great to see you a key thesis is you believe this investment of juul is a right one but you think this will incentivize altria to accelerate the declines they're already seeing i understand the declines have been going on for a very long time, but why are they incentivized now to see that go faster >> certainly, so as a function of the deal, juul

hearing yesterday and we also had -- yesterday was the 10th anniversary of president obama signing the lilly ledbetter act. this opened the door to more fairness in the workplace. yesterday, on the anniversary, delauroain,rosa we pass a it and number of times when we had the majority but we could not get the 60 votes in the senate so it was never taken up and out patty murray is a cosponsor -- the lead sponsor in the senate on that that is equal pay for equal work. yesterday was the 10th anniversary. april 2 is equal pay day. that is the day in which women start to get paid for their work for the year as opposed to what men make for the year so we hope this bill would be signed into law by that day. it's all a part of the for the people agenda for bigger paychecks, lower health care costs, more integrity in government. any questions? we've got the blue sign today. >> we match. during the shutdown, we heard president trump and his offering to provide three years of protection for it daca recipients. in the current negotiations, is that being discussed or our jailers getting lost in all of thi

lilly tan reports from modesto. >> reporter: a smile that launched a thousand laughs. >> you walk by him and he had that grin on his face. >> reporter: family came as far as fiji. and officers as far as canada. to say goodbye. >> we used to play with coconuts. when we first got our television, he started watching cops. >> what a shining star of an example. he is the best of us. someone who came over here from another country and worked hard to overcome so many obstacles. >> reporter: killed in the line of duty the day after christmas. his family thanked officers for making an arrest. >> i know this is what he wanted, he wanted justice and justice will be served. >> reporter: at his memorial service, the 33-year-old inspired just as many laughs as tears. >> ron wasn't a very good driver. he recked i believe three of our patrol cars. >> i was very hesitant to ride a mopped with him. >> people that he arrested coming up and saying even though he arrested me several times, we are going to miss him. we loved him. >>> and our microclimate weather alert underway as we are tracking scattered

if i can scroll down here, maybe lilly can help me do this. there we go. there is a position, and prior job. so why they left. did they resign under pressure? if you get promoted to senior position, you are had longer in that job and so with that in mind, you can see people, where they went. when took their place. and so 42 of the 65. after the piers year there are a lot resigning under pressure. i looked to see if i can find examples of 18 staff members resigning under pressure. and i found 1 or 2. national security advisor touring reagan administration that was sort of a controversial resignation. and with i had difficulty identifying other examples of resigning under pressure. if you're going to fire people, you're going to have high turn jefr rates. another thing president trump does is with taking people from another position. it's kind of like whack a mole and you're causing there is concern and i think if you're someone with a passion for maybe health care plsy or mrg policy, if you hef know from day-to-day who issing to be around. there are simulta

i want to welcome you to our meeting.ing -- 87th i and lillie mae from the city of fremont, california. mayor of baton rouge, louisiana. mayor of madison, wisconsin. rich davis, binghamton, new york. >> mesa, arizona. piscataway, new jersey. florida.gardens, atlanta, georgia. washington -- tacoma, w ashington. >> the mayors who stand before you are republicans, democrats, and independents, they come from cities both large and small, urban, rural, and suburban but the labels do not define us. what you see before us is one united group. a group that governs in real time, does not get distracted even by major disagreements and collectively work together to improve the lives of all of our residents. the nation's mayors are here in washington, d.c. to do what we do best, to solve problems and deliver results, a record turnout for our winter meetings. we are here to show washington how it is done and pushed them to address the critical needs of our cities and the real problems of americans across this great country face every single day. while washington remains mired in gridlock, the nation

bauhaus were writer editor and bell host random user front group use and designer and boat house master lilly right she curated major exhibitions and design furniture in interiors for a well known german industrialist but she's only being rediscovered no. use talking one hundred finally. a few years back some of lee heist furniture drawings turned up for sale. seeing them i realized the important role she had in fonda was work the furniture and particular that made me want to learn more about her. she wrote a book about the collaboration of architects muse from the lord and lee wright she was considered his equal at the time her influence on their joint projects has been largely forgotten or ignored. the historical narrative and historical research is almost always from a contemporaries perspective the questions asked were the ones that interested them at the time so these women were rediscovered when political and social discourse on the role of women in society began again. and in this anniversary year they're finally getting the attention they deserve these pioneers were young wild free sp

potential blockbuster drugs already unlock sold pipeline seem to have inspired a generous bid with lilly offering two hundred thirty five dollars per share for a walk so stock a premium of nearly seventy percent over locks those price at the close of trading on friday listen to this lock sold shares surged today by more than sixty five percent on the news of the merger just three dollars.

all of this is on the heels of that big deal by, of course, loxo oncology and eli lilly buying them fors why you're seeing the shares moving the way they are right now. if you take a look at the relative performance of biotech versus the s&p 500, over the course of the past year there may be a reason why some people are feeling at least a little bit better or at least a little bit more curious about what's happening with the pipeline. because if you look at that particular etf, the biotechnology stocks are trading at a bit of a discount to the overall s&p 500. treats all these companies on a more equal weighted basis. like the nasdaq, biotech ticker. but all of this will be made a little bit clearer in the 10:00 a.m. hour today when we've got a big interview. the ceo talking to david ricks about what it was. we know bristol-myers, pipelines, all of those big themes from these companies amidst the conference out in san francisco, california, happening right as we speak. back to you guys >> thank you very much >>> our next guest is predicting a big rally for global equities in 2019. rober

yesterday, eli lilly will buy luck so for a billion dollars. oversees health care coverage for bloomberg. i see you could use some help. drew: they seem to be involving oncology drugs. the pharmaceutical industry for the last year or so is been sitting on big piles of cash. .hey wanted to do something they need to refill the pipeline, they have problems to solve. valuations have been too high to go out and buy assets. there been some big pullbacks in the market. that's made some of those things must cheaper. -- much cheaper. we try to get some deals done. some valuations were too high. we have had these two big deals. we think there are probably more in the offing. we are heading for a time of transactions happening. things are lining up in the direction of money available, the need being there. all uh is a coming to a point where people are willing to bite. alix: we are hearing both sides. on the one hand, you have the ceo. >> my appetite is strong for that type of asset. base is $16 trillion. we gave 17% for next year. that does not include n

in september, she protested outside eli lilly headquarters. >> my son is not a statistic. his life saving medication was priced at a reasonable rate. >> reporter: minnesota's attorney general laurie swanson leaves office on monday but says her successor plans to continue the state's lawsuit. fda commissioner scott gottlieb says the fda is going to be changing the way they regulate insulin moving forward. >> at $1,300 a month, there must be a lot of people trying to ration. >> there are. he is certainly not the only one who's tried to ration his insulin which is very risky. >> frustrating to see so many redactions too, right? >> right. >> you can hardly read the thing. >> i'm glad we did the story. everyone i know who has had diabetes 1, 2, told me insulin prices are going through the roof and making it very difficult for them. all right, thank you. >>> china has challenged u.s. dominance here on earth for decades. now chinese ambitions reach all the way to the moon. ahead, a new space race takes flight with the first of its kind lunar landing. and if you're on the go, subs

eli lilly has agreed to buy loxxo for $8 billion in cash.n and it develops cancer drugs. sears preparing for a possible liquidation that could cost tens of thousands of jobs. bloomberg has learned the chairman's plan to buy several hundred stores out of bankruptcy, it fell short of qualifications. sears one-off focus on liquidation sales to begin as early as the middle this month. and president trump considering several moves as the government shutdown has moved into its third week. issays they ministers and planning a steel barrier on the mexico border, rather than a concrete wall. the white house hopes it could attract democratic support. he also says he will not rule out announcing a national emergency to circumvent congress and get border funding. david: we are not in the 17th day of the partial government shutdown, and although leaders met through the weekend, there is no ned insight -- end in sight. how made this change as time drags on? we still have with us lori calvasina, rbc's head of u.s. equity strategy. is it affecting the marke

irl yes today, nancy pelosi joined several other house democrats to re-introduce the lilly ledbetter. the bill. strengthen >> good morning. it is a great morning. so excited to be here. i'm rosa delaura and represent the 3rd district of connecticut.

eli lilly acquires. >> this is the largest transaction they have ever done according to bloomberg datait is interesting. $8 billion. investors like it. it is the big premium, but they do have an improved product. it is less risky. >> it is an incredible little company that took advantage of breaking science that allows doctors to identify the exact reason tumors are growing through genetic testing and then they made drugs. they block that action. it is entering the world of precision medicine. this adds to oncology. it is the kind of transaction we are interested in. strong innovation, compelling data in terms of survival. complete response rates. we are excited to add it. >> german industrial production took a big step down in the last year, raising the prospect of a technical recession and european economic confidence has fallen to its lowest in two years. what is going on? i tell you why i think markets are shrugging this off. this is data from november and around that time, both the bundesbank and finance ministry warned that germany would suffer through a slowdown in the latter pa

like lilly dash, hathty, netty rosenstein. >> one of the most exciting prints we have ever seen is designedmckartel. >> her making separates and ready to wear, not couture. >> she want. ed to design for the every woman. outdoors, athletic, function was very important. the dress had to work with a woman's lifestyle. >> she used common gingham, calico and they were very affordable for women to buy. >> she was champion of denim. a tex style that is associated with all things america and she brings them into the fashion arena. >> fashion was take iing a shif from what are the europeans wearing to the fashion industry is now designing for me. >> it was a startling moment for america. it was a big deal. >> claire led the way for many american designers. ann cline, donna karan, michael kors, they all have this american style. >> claire stopped going to the european shows and said i'm not going anymore because my creativity has to be original. she never went back to europe. she was making stuff in america for americans. >> you see this independence in america carving out its own unique identity. >>

just churning on >> eli lilly their cancer drug hits a s setback. >> they are taking 17% from earningslike to help the group. >> all right nxpi >> can i be honest with you? >> always. hold on, aren't you honest all the time >> i'm going to break some news. i don't like these calls lie that i can are saying, still not going to have any reven growth we looked at the whole semi sector and looking at them on enterprise value this one is selling at the biggest discount that's the reason to buy it. there's no real catalyst nothing is going well for the stock. i don't buy these types of upgrades i almost feel like they are ob will recolle ligatory >> emerging markets on pace since january 2018 >> we are over weight emerging markets. they really got beaten up last year going forward we think there's three important things to watch. first is the dollar. the fed stepping back a bit. our expectation is a flat line and the other two are all about china. trade and chinese policy makers to slowing growth. really trying to take a conservative approach. >> all right gold prices pulling back on track.

it was named lilly belle, after walt disney's wife, and carried japanese emperor hirohito on its maidenitance." thanks so much watching. and remember -- you can't take it with you. ♪ after suffering at their worst year for many global indices since 2008. stocks look to open sharply. nasdaq features at a hundred 39 points. as you can see there is a loss of 39 cents on the contract.

like lilly dache, hattie cartegy, nettie rosenstein. >> and claire mccardell, who's attributed to having which i mean casual clothing. >> one of the most exciting prints we have ever seen is designed by claire mccardell. she's shown here are tapered slack. >> claire mccardell making for the most part separates. it's ready to wear. it's not couture. >> she wanted to design for the everywoman, outdoors, athletic. function was very important. the dress had to work with a woman's lifestyle. >> she used common gingham. she used calico. and they were very affordable for women to buy. >> mccardell also was a champion of denim, a textile that is associated with all things america, and she brings them into the fashion arena. >> fashion was taking a shift from what are the europeans wearing to the fashion industry is now designing for me. >> it was a startling moment for america. it was a big deal. >> claire mccardell led the way for many american designers. ann cline, donna karan, michael kors, norma kamali. they all have this american style. >> claire mccardell stopped going to the european show

amount as the mean in the workplace and this comes 10 years after the then president obama signed the lilly ledbetter fair pay act. these are the advocates and women are still being paid $.80 on every dollar that men get paid. we will hear today from several congress members with our congresswoman jackie speier, barbara lee and house speaker nancy pelosi. we will keep an eye on washington dc. >>> it is 6:05 am. >>> here's a live look at chicago with chunks of ice in the chicago river running through the city right now. the dangerous cold spell is pumping through much of the midwest and the polar vortex already linked do several deaths with record low and wind chill factors as cold as 50 below zero. it is so cold that the u.s. postal service is suspending mail service. many schools, businesses and government offices are closed. many in the government are focused on protecting the vulnerable like the homeless and senior citizens. >>> the san francisco mayor london breed will give the first state of the city address at 11:30 am today at the national lgbtq center for the arts. one big issue is